Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLASH 2 study of finafloxacin-based regimens for Helicobacter pylori eradication
2009-011865-10Phase 2Completed
- Sponsor
- MerLion Pharmaceuticals
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of finafloxacin in Helicobacter pylori infection (3 arms), sponsored by MerLion Pharmaceuticals. Primary endpoint: Helicobacter pylori eradication. Started Jul 2009; status: completed.
02
Drugs
finafloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on 2009-011865-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011865-10.